Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma
暂无分享,去创建一个
K. Tarte | P. Hagner | S. Carrancio | F. Morschhauser | C. Bjorklund | E. G. Toraño | M. Delfau-Larue | A. Beldi-Ferchiou | A. Ramsay | Hsiling Chiu | A. Gandhi | Preeti Trisal | C. Guarinós | D. Papazoglou | P. Trisal